Experiences with cephalothin.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001419:Bacteria / Q000187:drug effects; D002512:Cephalothin / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D004342:Drug Hypersensitivity; D004698:Endocarditis, Subacute Bacterial / Q000188:drug therapy*; D006801:Humans; D066298:In Vitro Techniques; D008875:Middle Aged; D010406:Penicillins / Q000009:adverse effects; D011008:Pneumococcal Infections / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D010406:Penicillins; D002512:Cephalothin